18F-labeled styrylpyridines as PET agents for amyloid plaque imaging - PubMed (original) (raw)

18F-labeled styrylpyridines as PET agents for amyloid plaque imaging

Wei Zhang et al. Nucl Med Biol. 2007 Jan.

Abstract

Positron emission tomography (PET) imaging of beta-amyloid (Abeta) plaques in the brain is a potentially valuable tool for studying the pathophysiology of Alzheimer's disease (AD). It may also be applicable for measuring the effectiveness of therapeutic drugs aimed at lowering Abeta plaques in the brain. We have successfully reported a series of 18F-labeled fluoropegylated stilbenes for PET imaging studies. Encouraging results clearly demonstrated the usefulness of 18F-labeled stilbenes as potential Abeta plaque-imaging agents. In the present study, we applied a similar approach to a styrylpyridine backbone structure. Among all derivatives examined, (E)-2-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)-5-(4-dimethylaminostyryl)-pyridine (2) displayed high binding affinity in postmortem AD brain homogenates (Ki=2.5+/-0.4 nM, with [125I]IMPY as radioligand). No-carrier-added [18F]2 was successfully prepared by [18F]fluoride displacement of the corresponding tosylate precursor with a high labeling yield (30-40%) and a high radiochemical purity (>99%). Specific activity at the end of synthesis was determined to be 1500-2000 Ci/mmol. The tracer [18F]2 showed adequate lipophilicity (log P=3.22). In vivo biodistribution of [18F]2 in normal mice exhibited excellent initial brain penetration and rapid washout (7.77% and 1.03% dose/g in the brain at 2 and 30 min after intravenous injection, respectively)--properties that are highly desirable for Abeta-plaque-specific brain imaging agents. Autoradiography of AD brain sections and homogenate binding with postmortem AD brain tissues confirmed the high binding signal of [18F]2 due to the presence of Abeta plaques. These preliminary results suggest that novel PET tracers may be potentially useful for the imaging of Abeta plaques in the living human brain.

PubMed Disclaimer

Cited by

18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.
Kung HF, Choi SR, Qu W, Zhang W, Skovronsky D. Kung HF, et al. J Med Chem. 2010 Feb 11;53(3):933-41. doi: 10.1021/jm901039z. J Med Chem. 2010. PMID: 19845387 Free PMC article. No abstract available.
Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease.
Tong H, Lou K, Wang W. Tong H, et al. Acta Pharm Sin B. 2015 Jan;5(1):25-33. doi: 10.1016/j.apsb.2014.12.006. Epub 2015 Jan 2. Acta Pharm Sin B. 2015. PMID: 26579421 Free PMC article. Review.
Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer's brains.
Ono M, Hayashi S, Matsumura K, Kimura H, Okamoto Y, Ihara M, Takahashi R, Mori H, Saji H. Ono M, et al. ACS Chem Neurosci. 2011 May 18;2(5):269-75. doi: 10.1021/cn200002t. Epub 2011 Mar 21. ACS Chem Neurosci. 2011. PMID: 22778869 Free PMC article.
Optimization of Automatic Synthesis and Separation of [18F] AV-45 and Quality Control.
Zhang QZ, Li YB, Yilihamu N, Li XH, Ba Y, Qin YD. Zhang QZ, et al. Front Chem. 2022 Apr 12;10:826678. doi: 10.3389/fchem.2022.826678. eCollection 2022. Front Chem. 2022. PMID: 35494660 Free PMC article.
Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.
Ono M, Cheng Y, Kimura H, Watanabe H, Matsumura K, Yoshimura M, Iikuni S, Okamoto Y, Ihara M, Takahashi R, Saji H. Ono M, et al. PLoS One. 2013 Sep 13;8(9):e74104. doi: 10.1371/journal.pone.0074104. eCollection 2013. PLoS One. 2013. PMID: 24058519 Free PMC article.

18F-labeled styrylpyridines as PET agents for amyloid plaque imaging - PubMed (original) (raw)